10X GENOMICS KITS REAGENTS (AMBIS 2230829)
ID: RFQ-NIAID-24-2230829Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/8670639b9c2b48f4a9fb8488b083b43b/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking to procure 10X Genomics Kits Reagents. These kits are typically used for studying the systems biology of the host immune response to vector-borne pathogens on a global scale, and at single-cell resolution. The kits allow for transcriptional and cell surface protein profiling of tens of thousands of single cells in parallel, providing high-resolution insights into gene expression and cellular function. The procurement is a combined synopsis/solicitation for commercial items, with a total small business set-aside. The place of performance is Rockville, Maryland, and the delivery estimate is 45 days after receipt of order. Interested vendors must submit their quotes through the NIAID electronic Simplified Acquisition Submission System (eSASS) website. The deadline for submission is July 29, 2024, at 4:00 PM EST.

    Lifecycle
    Title
    Type
    10X GENOMICS KITS REAGENTS (AMBIS 2230829)
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to provide comprehensive whole genome sequencing, including variant interpretation and clinical reports, to enhance clinical research on infectious diseases, with results expected within four weeks of sample receipt. This initiative is critical for advancing the understanding of genetic factors in disease and improving patient care through genomic evaluations. Interested vendors must submit their quotes by 3:00 PM EST on September 13, 2024, to the primary contact, Seth Schaffer, at seth.schaffer@nih.gov, with the solicitation number RFQ-NIAID-24-2224314.
    PacBio Revio Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking procurement of PacBio Revio Reagents. This solicitation aims to acquire reagents that are critical for various analytical laboratory applications, particularly in the field of genomics and molecular biology. The goods are essential for conducting in vitro diagnostic tests, which play a significant role in research and clinical diagnostics. Interested vendors can reach out to Dorothy L. Maxwell at dorothy.maxwell@nih.gov or call 301-827-7729 for further details regarding the procurement process.
    Downstream Development Biolayer Interferometer Instrument: GatorPivot 16 Channel and Gator Pro 32 Channel Systems- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two Biolayer Interferometer Instruments, namely the GatorPivot 16 Channel and Gator Pro 32 Channel systems, to support monoclonal antibody and vaccine development projects. The instruments are critical for high-throughput quantification of proteins and protein epitopes, essential for vaccine efficacy and regulatory approval processes. Interested vendors must submit their quotes by September 13, 2024, with the expectation of delivery within 90 days post-award, and are encouraged to demonstrate their capability to meet the specified technical requirements. For inquiries, vendors can contact Hershea Vance at hershea.vance@nih.gov or Linda Smith at linda.smith2@nih.gov.
    Cell Analyzers– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of eight advanced cell analyzers to support the Vaccine Research Center's (VRC) research initiatives. The required analyzers must possess specific capabilities, including at least five lasers with expansion potential, the ability to detect a minimum of 50 parameters, and features that ensure high throughput sampling and compatibility with existing research tools. This acquisition is critical for maintaining data integrity and enhancing the VRC's capacity to conduct complex immunological studies, with a firm-fixed-price purchase order expected to be awarded. Interested vendors must submit their quotes by 3:00 PM EST on September 13, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all outlined specifications and requirements.
    STANDING ORDER FOR NOVA BIOMEDICAL LABORATORY SUPPLIES
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking quotes for a standing order of Nova Biomedical laboratory supplies. This procurement, identified by solicitation number RFQ-NIAID-24-2230810, requires specific brand-name items essential for laboratory operations, including various microsensor cards and calibrator cartridges, with a total quantity of 44 items to be delivered in multiple shipments over the next year. The selected contractor will be awarded a firm fixed-price purchase order based on technical capability and pricing, with submissions due by September 3, 2024, at 12:00 PM EST. Interested vendors should direct inquiries to Maliaka Pinkney at maliaka.pinkney@nih.gov or call 240-669-5308.
    ZEISS DISCOVERY V12 DISSECTING AND ZEISS STEMI 305 DISSECTING SCOPE MICROSCOPES
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking quotes for the procurement of Zeiss Discovery V12 Dissecting and Zeiss Stemi 305 Dissecting Scope Microscopes. This acquisition, which falls under the NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, requires specific brand-name equipment to support the National Institute of Allergy and Infectious Diseases (NIAID) in its research activities. The contract will be awarded based on technical capability and price, with a submission deadline of September 16, 2024, at 5:00 PM EST. Interested vendors should direct inquiries to Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D Weidow at weidowjd@niaid.nih.gov, and must submit their offers via the NIH's Simplified Acquisition Submission System (eSASS).
    Notice of Intent: Gemini Bio-GemCell TM Plus Xeno free Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole-source contract to Gemini Bio for the supply of GemCell™ Plus Xeno-Free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. This procurement is critical as the Center relies on these specific reagents for manufacturing human cell and tissue-based products used in clinical trials, which are vital for patient care and treatment protocols. The unique compatibility of Gemini Bio's products with existing manufacturing processes makes them the only viable source, as switching vendors would incur significant costs and delays, potentially impacting patient outcomes. Interested parties may submit capability statements to Sheri Eiri at sheri.eiri@nih.gov by September 8, 2024, at 12:00 PM EST for consideration.
    Sequencing reagents and flow cells
    Active
    National Aeronautics And Space Administration
    NASA's National Aeronautics and Space Administration (NASA) is seeking to procure sequencing reagents and flow cells, which are critical for RNA sequencing from various tissues collected during space missions. This procurement is part of the NASA GeneLab project, aimed at expanding the volume and utility of omics data from spaceflight experiments, and the reagents must be compatible with the Illumina NovaSeq 6000 platform to ensure effective library preparation and sequencing. The selected contractor will deliver the required reagents to the NASA Ames Research Center within 15 days post-contract award, with options for partial deliveries, emphasizing NASA's commitment to advancing biological research. Interested organizations must submit their capabilities and qualifications in writing to Sara Jusino-Terry at sara.a.jusino-terry@nasa.gov by 12 p.m. Central Standard Time on September 9, 2024, to be considered for this sole source contract with Illumina, Inc.
    Brand-Name or Equal Upgrade of Opera Phenix Plus with Multiple Units
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the upgrade of the Opera Phenix Plus system, which includes multiple units aimed at enhancing laboratory capabilities. The procurement encompasses several specific items, including environmental control upgrades, liquid handling systems, and robotic live cell imaging components, all of which are critical for advancing high-content screening in scientific research. This acquisition is part of the NIH's commitment to support cutting-edge technology in laboratory environments, with a firm fixed-price purchase order anticipated to be awarded by September 12, 2024. Interested vendors must submit their quotations by 4:00 PM EDT on September 9, 2024, to the Contracting Officer, Mark McNally, at mark.mcnally@nih.gov.